Navigation Links
Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis

Announces Positive Data in Animal Models of Ulcerative Colitis

NEW YORK, April 05, 2007 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. , a developer of new drug treatments in the fight against cancer and other major health threats, announced today additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis. Guanilib is an orally deliverable compound designed to mimic a naturally-occurring hormone called uroguanylin. The drug is currently in preclinical development and Callisto intends to move the drug into clinical trials in ulcerative colitis. Guanilib is a proprietary program that was developed in-house by Callisto scientists and the company owns 100% of the worldwide manufacturing and marketing rights.

The new animal data demonstrate that oral administration of Guanilib significantly reduces gastrointestinal (GI) inflammation, and confirm earlier evidence of down-regulation of interleukin-17 (IL-17), IL-23, and tumor necrosis factor (TNF), key cytokines that are known to be involved in etiology of IBD in humans. Guanilib treatment also improved stool consistency and removed intestinal blockage in treated animals.

"These are important findings and suggest a possible mechanism of action of Guanilib and implicate its therapeutic potential in GI inflammatory diseases such as IBD and IBS," said Dr. Kunwar Shailubhai, Senior Vice President, Discovery Research of Callisto, who is also the lead inventor of the issued patent covering therapeutic applications of Guanilib in GI inflammatory diseases and colon cancer.

Callisto believes that Guanilib is presently the best physiological ligand of guanylate cyclase receptor with the potential to provide a new way to treat gastrointestinal diseases, while exhibiting minimal side effects
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:9/30/2014)...  According to their CEO, Rob Bohacs ... is going through a complete transformation with highly ... the current clinical trial management process isn,t configured ... trials, which will ultimately drive the prescription cancer ... has been recognized by the National Cancer Institute as ...
(Date:9/30/2014)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), ... and commercialization of prescription ophthalmic pharmaceuticals, announced today that ... Technology Growth Capital, Inc. (NYSE: HTGC ) ... under the Loan and Security Agreement that Alimera,s subsidiary ... Sciences Limited, entered into with Hercules in April of ...
(Date:9/30/2014)... , Sept. 30, 2014 A study ... (OCT), offered a new look at the composition of ... how physicians understand and treat the disease, a leading ... at Baptist Health Lexington between September 2010 and May ... the Journal of the American College of Cardiology ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... 15, 2011 ULURU Inc. (NYSE AMEX: ... on the development of a portfolio of wound management ... into agreements for investment commitments with Ironridge Global BioPharma ... in two transactions, subject to certain conditions, to purchase ...
... 15, 2011 VIVUS, Inc. (NASDAQ: VVUS ) ... agreement with officials of the Endocrine and Metabolic Division of ... for an early resubmission of the QNEXA New Drug Application ... to seek approval for an initial indication that includes obese ...
Cached Medicine Technology:ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 2ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 3VIVUS Provides Regulatory Update on QNEXA 2VIVUS Provides Regulatory Update on QNEXA 3VIVUS Provides Regulatory Update on QNEXA 4
(Date:10/1/2014)... 2014 Indosoft, Inc., a leading provider of ... it has added support for Sangoma Lyra ... Indosoft have a history of bringing innovative products to ... offers a significant benefit to those using Asterisk as a ... available to users of Q-Suite. , In the past decades, ...
(Date:10/1/2014)... October 01, 2014 QueenBeeTickets.com is giving music ... the singer’s upcoming North American tour, which has him traveling ... come. , Click here to view the selection ... performer’s newest album, is due to come out on October ... shortly thereafter. Bob Seger concert tickets are available for shows ...
(Date:9/30/2014)... in developing countries may have no intention of working ... one fifth of them intend to work in rural ... new study. , Health workforce shortages have been a ... western Africa. The disease initially spread rapidly in rural ... Sierra Leone and Liberia), where health workers are scarcest. ...
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, 2014 (HealthDay ... the brakes on motherhood. And for many young women, that ... research suggests. Women in their early 20s appear most ... economic times. But, according to the new study, that means ... and beyond. The findings suggest that higher unemployment "will ...
(Date:9/30/2014)... 30, 2014 (HealthDay News) -- Sleep apnea is a potential ... points to a possible culprit behind the disorder: a "fat" ... fat deposits are increased in the tongue of obese patients ... co-director of the Sleep Center at the University of Pennsylvania ... , which will publish the findings Oct. 1. Sleep ...
Breaking Medicine News(10 mins):Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2Health News:Bob Seger Presale Tickets: QueenBeeTickets.com Delights Fans with Discounted Tickets for All 20 Stops on Seger’s “Ride Out” Tour with The Silver Bullet Band 2Health News:Developing countries should enroll medical and nursing students from rural areas 2Health News:Developing countries should enroll medical and nursing students from rural areas 3Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 2Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 3Health News:Could a 'Fat Tongue' Be a Factor in Sleep Apnea? 2
... results with less inconvenience, study finds , WEDNESDAY, Feb. ... breast cancer surgery do just as well with three ... study suggests. , "We consider this [finding] a win-win ... health-care system," said study author Dr. Timothy J. Whelan, ...
... lower Manhattan residents suggest a link, nearly a decade ... 10 years after the 9/11 attacks, residents and workers ... Center site appear prone to persistent, sometimes severe headaches, ... study author Dr. Sara C. Crystal, an instructor in ...
... at the heart of Europe, provides a fitting setting ... Society of Cardiology Council (ESC) on Cardiovascular Nursing and ... its special theme: "Uniting to Improve Cardiovascular Practice". ... developed different ways of managing them. The idea of ...
... , BELGRADE ... www.hirucorporation.com ) and its European subsidiary MindUp BioResearch ( www.mindupbioresearch.com ... Sabera Ruzdijic,s patents. Dr. Sabera Ruzdijic is the project ... team leaders in MindUp Research project are Dr. Nikola Tanic ...
... lead to new vaccines, treatments, researchers say , WEDNESDAY, ... discovered the origin of strains of the AIDS virus ... the origin of the transmitted virus, scientists may be ... to prevent the spread of sexually transmitted HIV," study ...
... connection noted after surgical removal of tumors, study found , ... of the brain boosted levels of spiritual thinking and feeling ... connection between religious attitudes and the physical makeup of the ... 11 issue of Neuron , are based on research ...
Cached Medicine News:Health News:For Some Breast Cancer Patients, Shorter Radiation Works Well 2Health News:For Some Breast Cancer Patients, Shorter Radiation Works Well 3Health News:Exposure to 9/11 Fumes Tied to Chronic Headaches 2Health News:Exposure to 9/11 Fumes Tied to Chronic Headaches 3Health News:Nurses unite to improve cardiovascular practice 2Health News:Nurses unite to improve cardiovascular practice 3Health News:Nurses unite to improve cardiovascular practice 4Health News:Nurses unite to improve cardiovascular practice 5Health News:Nurses unite to improve cardiovascular practice 6Health News:MindUp (HIRU) Patents in the World Patent Database 2Health News:MindUp (HIRU) Patents in the World Patent Database 3Health News:Scientists Discover How HIV Is Transmitted Between Men 2Health News:Physical Changes in Brain Linked to Altered Spirituality 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: